Vanessa L Kronzer1, Weixing Huang2, Alessandra Zaccardelli2, Cynthia S Crowson3, John M Davis4, Robert Vassallo5, Tracy J Doyle6, Elena Losina7, Jeffrey A Sparks2. 1. V.L. Kronzer, MD MSCI, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota; kronzer.vanessa@mayo.edu. 2. W. Huang, MSPH, A. Zaccardelli, BS, J.A. Sparks, MD, MMSc, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 3. C.S. Crowson, PhD, Division of Rheumatology, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota. 4. V.L. Kronzer, MD MSCI, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota. 5. R. Vassallo, MD, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota. 6. T.J. Doyle, MD, MPH, Division of Pulmonary and Critical Care, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 7. E. Losina, PhD, Department of Orthopedic Surgery; Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: We aimed to determine whether specific respiratory tract diseases are associated with increased rheumatoid arthritis (RA) risk. METHODS: This case-control study within the Mass General Brigham Biobank matched newly diagnosed RA cases to 3 controls on age, sex, and electronic health record history. We identified RA using a validated algorithm and confirmed by medical record review. Respiratory tract disease exposure required 1 inpatient or 2 outpatient codes at least 2 years before the index date of RA clinical diagnosis or matched date. Logistic regression models calculated ORs for RA with 95% CIs, adjusting for confounders. We then stratified by serostatus ("seropositive" was positive rheumatoid factor and/or anticitrullinated protein antibodies) and smoking. RESULTS: We identified 741 RA cases and 2223 controls (both median age 55, 76% female). Acute sinusitis (OR 1.61, 95% CI 1.05-2.45), chronic sinusitis (OR 2.16, 95% CI 1.39-3.35), and asthma (OR 1.39, 95% CI 1.03-1.87) were associated with increased risk of RA. Acute respiratory tract disease burden during the preindex exposure period was also associated with increased RA risk (OR 1.30 per 10 codes, 95% CI 1.08-1.55). Acute pharyngitis was associated with seronegative (OR 1.68, 95% CI 1.02-2.74) but not seropositive RA; chronic rhinitis/pharyngitis was associated with seropositive (OR 2.46, 95% CI 1.01-5.99) but not seronegative RA. Respiratory tract diseases tended towards higher associations in smokers, especially > 10 pack-years (OR 1.52, 95% CI 1.02-2.27, P = 0.10 for interaction). CONCLUSION: Acute and chronic sinusitis, pharyngitis, and acute respiratory burden increased RA risk. The mucosal paradigm of RA pathogenesis may involve the upper respiratory tract.
OBJECTIVE: We aimed to determine whether specific respiratory tract diseases are associated with increased rheumatoid arthritis (RA) risk. METHODS: This case-control study within the Mass General Brigham Biobank matched newly diagnosed RA cases to 3 controls on age, sex, and electronic health record history. We identified RA using a validated algorithm and confirmed by medical record review. Respiratory tract disease exposure required 1 inpatient or 2 outpatient codes at least 2 years before the index date of RA clinical diagnosis or matched date. Logistic regression models calculated ORs for RA with 95% CIs, adjusting for confounders. We then stratified by serostatus ("seropositive" was positive rheumatoid factor and/or anticitrullinated protein antibodies) and smoking. RESULTS: We identified 741 RA cases and 2223 controls (both median age 55, 76% female). Acute sinusitis (OR 1.61, 95% CI 1.05-2.45), chronic sinusitis (OR 2.16, 95% CI 1.39-3.35), and asthma (OR 1.39, 95% CI 1.03-1.87) were associated with increased risk of RA. Acute respiratory tract disease burden during the preindex exposure period was also associated with increased RA risk (OR 1.30 per 10 codes, 95% CI 1.08-1.55). Acute pharyngitis was associated with seronegative (OR 1.68, 95% CI 1.02-2.74) but not seropositive RA; chronic rhinitis/pharyngitis was associated with seropositive (OR 2.46, 95% CI 1.01-5.99) but not seronegative RA. Respiratory tract diseases tended towards higher associations in smokers, especially > 10 pack-years (OR 1.52, 95% CI 1.02-2.27, P = 0.10 for interaction). CONCLUSION: Acute and chronic sinusitis, pharyngitis, and acute respiratory burden increased RA risk. The mucosal paradigm of RA pathogenesis may involve the upper respiratory tract.
Authors: Lars Klareskog; Patrik Stolt; Karin Lundberg; Henrik Källberg; Camilla Bengtsson; Johan Grunewald; Johan Rönnelid; Helena Erlandsson Harris; Ann-Kristin Ulfgren; Solbritt Rantapää-Dahlqvist; Anders Eklund; Leonid Padyukov; Lars Alfredsson Journal: Arthritis Rheum Date: 2006-01
Authors: V Michael Holers; M Kristen Demoruelle; Kristine A Kuhn; Jane H Buckner; William H Robinson; Yuko Okamoto; Jill M Norris; Kevin D Deane Journal: Nat Rev Rheumatol Date: 2018-09 Impact factor: 20.543
Authors: Solbritt Rantapää-Dahlqvist; Ben A W de Jong; Ewa Berglin; Göran Hallmans; Göran Wadell; Hans Stenlund; Ulf Sundin; Walther J van Venrooij Journal: Arthritis Rheum Date: 2003-10
Authors: Vanessa L Kronzer; Weixing Huang; Cynthia S Crowson; John M DavisIII; Robert Vassallo; Tracy J Doyle; Elena Losina; Jeffrey A Sparks Journal: Semin Arthritis Rheum Date: 2021-12-31 Impact factor: 5.532
Authors: Victor M Castro; Vivian Gainer; Nich Wattanasin; Barbara Benoit; Andrew Cagan; Bhaswati Ghosh; Sergey Goryachev; Reeta Metta; Heekyong Park; David Wang; Michael Mendis; Martin Rees; Christopher Herrick; Shawn N Murphy Journal: J Am Med Inform Assoc Date: 2022-03-15 Impact factor: 4.497